肿瘤营养市场研究报告按产品类型（口服营养补充剂、肠内营养、肠外营养、功能食品）、按癌症类型（乳腺癌、结直肠癌、肺癌、前列腺癌）、按最终用户（医院、护理机构、门诊护理中心）、按分销渠道（在线药房、零售药房、医院药房）和按地区（北美、欧洲、南美、亚太地区、中东和非洲）-预测到2034年
ID: MRFR/HC/32288-HCR | 100 Pages | Author: Rahul Gotadki| July 2025
| Report Attribute/Metric | Details |
| Market Size 2024 | 17.22 (USD Billion) |
| Market Size 2025 | 18.16 (USD Billion) |
| Market Size 2034 | 29.36 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.48 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Market Forecast Units | USD billion |
| Key Companies Profiled | Reckitt Benckiser, Milupa, Hormel Foods, Abbott Laboratories, Bristol-Myers Squibb, Genentech, Nestle, Danone, Baxter International, Fresenius Kabi, Nutricia, Mead Johnson Nutrition, Pacific Nutritional, Eleanor's |
| Segments Covered | Product Type, Cancer Type, End User, Distribution Channel, Regional |
| Key Market Opportunities | Aging population health management, Personalized nutrition solutions, Innovative delivery formats, Expanding dietary supplement range, Increased awareness and education |
| Key Market Dynamics | rising cancer prevalence, increasing awareness of nutrition, growth in personalized nutrition, advancements in food technology, supportive government regulations |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Oncology Nutrition Market is expected to be valued at 29.36 USD billion in 2034.
The projected CAGR for the Oncology Nutrition Market is 5.48% from 2025 to 2034.
North America is expected to dominate the Oncology Nutrition Market with a value of 10.5 USD billion in 2032.
The market size of Oral Nutritional Supplements is expected to reach 9.85 USD billion in 2032.
The Enteral Nutrition segment is expected to be worth 6.55 USD billion in 2032.
Key players include Reckitt Benckiser, Abbott Laboratories, Nestle, and Fresenius Kabi among others.
The market size of Parenteral Nutrition is expected to be 4.0 USD billion in 2032.
The Functional Foods segment is expected to reach 4.6 USD billion in 2032.
The APAC region is expected to contribute 5.0 USD billion to the Oncology Nutrition Market by 2032.
The market value for South America is expected to reach 2.5 USD billion in 2032.
Comments
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
